Search results for: 'medgen and acquisition deaf and alliance of 221b'
- Did you mean
- merger and acquisition deal and alliance of 2016
- Related search terms
- Acquisition Terms and Agreements in Pharma
- acquisition texas and agreements in pharma
- medgen and acquisition deal of 2017
- medgen and acquisition deal and alliance of 2015
- deaf+texas+and+benchmarking
-
Vaccine Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Gene Editing Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Gene Editing Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Global Specialty Pharmaceutical Partnering Terms and Agreements 2019-2024October 2024$3,995.00Global Specialty Pharmaceutical Partnering Terms and Agreements 2019 to 2024 report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals.
Learn More -
Oncology Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Molecular Diagnostics Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Molecular Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Genitourinary Collaboration and Licensing Deals 2016-2024October 2024$3,995.00Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Distribution Deals in Diagnostics 2016-2024September 2024$3,995.00Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Diagnostic Collaboration and Licensing Deals 2020-2024November 2024$3,995.00Diagnostics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2020 to 2024
Learn More -
Big Pharma Partnering Terms and Agreements 2020-2024October 2024$3,995.00Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals
Learn More
